Coleman RE - Search Results

1

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.

Coleman RE, Banks LM, Girgis SI, Kilburn LS, Vrdoljak E, Fox J, Cawthorn SJ, Patel A, Snowdon CF, Hall E, Bliss JM, Coombes RC; Intergroup Exemestane Study group. Coleman RE, et al. Lancet Oncol. 2007 Feb;8(2):119-27. doi: 10.1016/S1470-2045(07)70003-7. Lancet Oncol. 2007. PMID: 17267326 Clinical Trial.

2

Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer.

Soukop M, McQuade B, Hunter E, Stewart A, Kaye S, Cassidy J, Kerr D, Khanna S, Smyth J, Coleman R, et al. Soukop M, et al. Oncology. 1992;49(4):295-304. doi: 10.1159/000227060. Oncology. 1992. PMID: 1387929 Clinical Trial.

3

Advanced breast cancer in Egyptian women: clinical features and response to endocrine therapy. The Anglo-Egyptian Health Agreement Collaborative Study.

Richards MA, Coleman RE, Hamsa R, Khaled H, el Mawla MG, Kadry I, Hablas A, Ramadan M, Allen D, Wang DY, et al. Richards MA, et al. Among authors: coleman re. Eur J Surg Oncol. 1992 Jun;18(3):219-23. Eur J Surg Oncol. 1992. PMID: 1607031

4

Selection of patients with breast cancer for routine follow-up bone scans.

Coleman RE, Fogelman I, Habibollahi F, North WR, Rubens RD. Coleman RE, et al. Clin Oncol (R Coll Radiol). 1990 Nov;2(6):328-32. doi: 10.1016/s0936-6555(05)80995-1. Clin Oncol (R Coll Radiol). 1990. PMID: 2278890 Clinical Trial.

5

Clinically available evaluation of bone disease in breast cancer--validity and cost effectiveness.

Coleman RE. Coleman RE. Can J Oncol. 1995 Dec;5 Suppl 1:69-79. Can J Oncol. 1995. PMID: 8853529 Review.

6

The future of bisphosphonates in cancer.

Coleman RE, Purohit OP, Vinholes JJ. Coleman RE, et al. Acta Oncol. 1996;35 Suppl 5:23-9. doi: 10.3109/02841869609083964. Acta Oncol. 1996. PMID: 9142961 Review.

7

Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease.

Vinholes JJ, Purohit OP, Abbey ME, Eastell R, Coleman RE. Vinholes JJ, et al. Among authors: coleman re. Ann Oncol. 1997 Dec;8(12):1243-50. doi: 10.1023/a:1008238422151. Ann Oncol. 1997. PMID: 9496390 Free article. Clinical Trial.

8

A randomised phase II study of oral pamidronate for the treatment of bone metastases from breast cancer.

Coleman RE, Houston S, Purohit OP, Rubens RD, Kandra A, Ford J. Coleman RE, et al. Eur J Cancer. 1998 May;34(6):820-4. doi: 10.1016/s0959-8049(97)10155-1. Eur J Cancer. 1998. PMID: 9797692 Clinical Trial.

9

Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease.

Coleman RE, Purohit OP, Black C, Vinholes JJ, Schlosser K, Huss H, Quinn KJ, Kanis J. Coleman RE, et al. Ann Oncol. 1999 Mar;10(3):311-6. doi: 10.1023/a:1008386501738. Ann Oncol. 1999. PMID: 10355575 Free article. Clinical Trial.

10

VEDex (vincristine, epirubicin dexamethasone): an effective and well tolerated palliative chemotherapy regimen for non-Hodgkin's lymphoma.

El Helw LM, Lorigan PC, Robinson MH, Coleman RE, Hancock BW. El Helw LM, et al. Among authors: coleman re. Int J Oncol. 2000 Apr;16(4):777-82. doi: 10.3892/ijo.16.4.777. Int J Oncol. 2000. PMID: 10717248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,028 results

Search Page